Cross-institution positioning
Aug 7, 2026Strong institutional reduction. 1 reducing, 3 exited across 4 comparable institutions.
Source: Schedule 13 researchAmerican Healthcare REIT, Inc.
Latest stored close $50.44 as of Oct 8, 2026 View live quote ↗
See how each tracked institution's reported ownership changed across SEC position dates. Full history is available with Investor or Pro access.
What the evidence shows across the newest institutional, insider, company-event, 13F, fundamental, and price data; STOCKNODE combines these layers into a quantitative research signal while preserving each source and reporting window.
Strong institutional reduction. 1 reducing, 3 exited across 4 comparable institutions.
Source: Schedule 13 research0 increased/new, 2 reduced/exited across 2 managers in the latest comparable Form 13F quarter.
Source: Form 13F quarter-end holdingsOver the last 90 days, SEC-coded non-derivative P/S activity includes 0 purchases by 0 reporting owners and 2 sales by 1 reporting owner. Amendments are shown in the filing evidence but excluded from rolling activity totals.
Source: SEC Forms 3/4/511 non-amendment material events in the last 90 days; 2 capital-related filing/events; Latest classified evidence: Regulation FD disclosure. Registration and prospectus filings are treated as financing capacity/disclosure evidence, not proof that securities were sold.
Source: SEC 8-K / securities filing metadataRevenue +26.6% YoY; Net income +208.9% YoY. Periods are compared only when the SEC facts are aligned and comparable.
Source: SEC Company FactsRecent close is 70% through its reported 52-week range; +24.1% over one year.
Source: Stored historical price seriesFiled Aug 7, 2026. Unlock the dated position comparison, disclosure classification, confidence, price context, and filing-specific significance analysis.
Premium research values are withheld until unlocked.
The research summary above gives the current read. This section shows the dated holder-level evidence behind it.
See each institution's newest reported position against its own prior report, with position as-of date separated from SEC filed date. Institution names and filing freshness remain public below.
Comparable holder direction grouped by SEC position as-of date — never presented as trade dates.
Compare each institution only with its own prior reported position. Public visitors can see who is tracked and how fresh the filing is; paid research reveals the actual comparison.
Investor and Pro reveal holder-by-holder changes, reported ownership history, dated breadth, disclosure timing, institution comparison, and filing-specific analysis without treating Schedule 13 reports as trade dates.
Reported Section 16 ownership activity. Rolling purchase/sale totals use non-derivative SEC transaction codes P and S only; amendments remain visible but are excluded from those totals.
| Date | Reporting owner | Code | Security | Shares | Price | Ownership | Filed |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Foster Mark E. | SOpen-market or private sale | Common Stock | 1.5K | $52.06 | Direct | Sep 28, 2026 |
| Sep 1, 2026 | Foster Mark E. | SOpen-market or private sale | Common Stock | 2.0K | $55.39 | Direct | Sep 1, 2026 |
| Jul 21, 2026 | Prosky Danny | AGrant, award, or other acquisition · amendment | Common Stock | 2.6K | $0.00 | Direct | Aug 4, 2026 |
| Jul 21, 2026 | Prosky Danny | MExercise or conversion of derivative · derivative | Restricted Stock Units | 20.9K | $0.00 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 30.9K | $0.00 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | AGrant, award, or other acquisition | Common Stock | 2.6K | $0.00 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | FTax/price withholding or payment | Common Stock | 11.3K | $56.66 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | MExercise or conversion of derivative | Common Stock | 20.9K | — | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | FTax/price withholding or payment | Common Stock | 16.7K | $56.66 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | MExercise or conversion of derivative | Common Stock | 30.9K | — | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Prosky Danny | FTax/price withholding or payment | Common Stock | 59.9K | $56.66 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Willhite Gabriel M | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 6.0K | $0.00 | Direct | Jul 22, 2026 |
| Jul 21, 2026 | Hanson Jeffrey T | AGrant, award, or other acquisition · derivative | Restricted Stock Unit | 36.0K | $0.00 | Direct | Jul 22, 2026 |
| Apr 6, 2026 | Foster Mark E. | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 3.0K | $0.00 | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Foster Mark E. | FTax/price withholding or payment | Common Stock | 1.6K | $48.09 | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Foster Mark E. | MExercise or conversion of derivative | Common Stock | 3.0K | — | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Oh Stefan K.L. | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 3.2K | $0.00 | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Oh Stefan K.L. | FTax/price withholding or payment | Common Stock | 1.6K | $48.09 | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Oh Stefan K.L. | MExercise or conversion of derivative | Common Stock | 3.2K | — | Direct | Apr 8, 2026 |
| Apr 6, 2026 | Willhite Gabriel M | MExercise or conversion of derivative · derivative | Restricted Stock Unit | 6.8K | $0.00 | Direct | Apr 8, 2026 |
Recent 8-K item classifications plus securities registration and prospectus filings. Registration or prospectus filings show financing capacity/disclosure activity; they do not by themselves prove that securities were sold.
| Filed | Form | 8-K item(s) | Classification | Capital context | SEC |
|---|---|---|---|---|---|
| Sep 18, 2026 | 8-K | 7.01, 8.01, 9.01 | Regulation FD disclosure; Other event; Financial statements / exhibits | — | Filing |
| Sep 14, 2026 | 8-K | 7.01 | Regulation FD disclosure | — | Filing |
| Sep 2, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Sep 1, 2026 | 8-K | 7.01, 9.01 | Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Aug 24, 2026 | 8-K | 8.01, 9.01 | Other event; Financial statements / exhibits | — | Filing |
| Aug 12, 2026 | 8-K | 8.01 | Other event | — | Filing |
| Aug 11, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| Aug 10, 2026 | 424B5 | — | Prospectus filing | Capital-related | Filing |
| Aug 10, 2026 | 8-K | 1.01 | Material definitive agreement | — | Filing |
| Aug 6, 2026 | 8-K | 2.02, 7.01, 9.01 | Results of operations / financial condition; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jul 22, 2026 | 8-K | 5.02, 7.01, 9.01 | Director or executive change; Regulation FD disclosure; Financial statements / exhibits | — | Filing |
| Jun 25, 2026 | 8-K | 5.07 | Shareholder vote results | — | Filing |
Period-aligned SEC facts. Comparisons appear only when periods and units are comparable.
| Period | Revenue | YoY |
|---|---|---|
| Ended Jun 30, 2026 | $634.5M | +26.6% |
| Ended Jun 30, 2025 | $501.3M | — |
Dated price context from the historical market series already collected for this security.
Returns are close-to-close price changes. Volatility and drawdown are factual historical context, not recommendations.
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Vanguard Capital Management CIK0002100119 | Jun 30, 2026 quarter end Aug 13, 2026 filed Form 13F quarter-end evidence | Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal. | 9.2M | $50.44 | |||
| State Street CIK0000093751 | Jun 30, 2026 observed Aug 7, 2026 filed · 38d Initial Schedule 13G | Initial Schedule 13G | 9.0M -499.0K | 4.30% -7.70 pts | $52.15 | $56.74 | $50.44 |
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 27, 2026 filed · 27d Schedule 13G amendment | Reported reduction | 22.2M -2.4M | 12.00% -1.20 pts | $52.15 | $57.45 | $50.44 |
Compare AHR with other securities showing similar institutional activity or recent accumulation across several tracked institutions.